JRM-001

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameJRM-001

Drug Alias NameJRM-001

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Cardiac stem cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsUniventricular HeartHypoplastic Left Heart Syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesJapan Regenerative Medicine Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesMetcela Inc

Inactive CompaniesN/A

Active IndicationsUniventricular HeartHypoplastic Left Heart Syndrome

Inactive IndicationsN/A

Other Information

ATC CodeN/A